Skip to main content
. 2020 Jun 30;25:64. doi: 10.4103/jrms.JRMS_560_17

Table 2.

Logistic regression analysis of factors associated with nonalcoholic fatty liver disease in type 2 diabetes mellitus and established ischemic heart disease patients

Variables OR (CI) P
SBP 2.5 (0.9–6.8) 0.07
DBP 1.5 (0.5–3.9) 0.43
BMI 4.6 (1.6–13.6) 0.006
HbA1c 2.8 (1.1–6.9) 0.032
TG 0.2 (0.2–1.3) 0.51
LDL 0.6 (0.2–1.8) 0.55
HDL-C 3.1 (1.2–7.5) 0.012
CIMT 2.5 (0.8–7.9) 0.126

Clinical parameters according to severity of ultrasonography-diagnosed NAFLD

Variables (n) NAFLD-2 (n=48; 32%) NAFLD-1 (n=59; 39%) Non-NAFLD (n=43; 29%) P

SBP (mmHg), mean±SD 140±19 133±15.0 128±15.7 <0.001
DBP (mmHg), mean±SD 81±13.0 83±13 77±13 0.001
BMI (kg/m2), mean±SD 33.8±6.7 30.0±7.8 26.0±3.8 <0.001
WC (cm), mean±SD 106±13 102±10 89±14 <0.001
HbA1c (%), median (IQR) 9.3 (2.4) 8.2 (5.8) 8.0 (2.2) <0.001
ALT (U/L), median (IQR) 33 (25) 20 (20.8) 22 (17) 0.601
GGT (U/L), median (IQR) 59 (39) 38 (31) 36 (26) 0.079
ALP (U/L), median (IQR) 80 (40) 83 (27) 82 (32) 0.707
TG (mmol/L), median, (IQR) 1.8 (0.9) 1.6 (0.8) 1.5 (1.1) 0.002
LDL (mmol/L), mean±SD 3.2±1.5 2.6±1.1 2.4±0.9 0.04
CIMT (mm), mean±SD 0.77±0.19 0.69±0.14 0.68±0.32 0.018

Data are presented as mean±SD for parametric data and median (IQR) for nonparametric data. Categorical data are presented as numbers of patients and percentages. Comparison for different stages in NAFLD was analyzed using Chi-square test for categorical variables and ANOVA test for continuous variables. P<0.05 is considered statistically significant. SD=Standard deviation; ANOVA=Analysis of variance; IQR=Interquartile range; NAFLD=Nonalcoholic fatty liver disease; OR=Odds ratio; CI=Confidence interval; SBP=Systolic blood pressures; DBP=Diastolic blood pressures; BMI=Body mass index; HbA1c=Glycated hemoglobin; TG=Triglyceride; LDL=Low-density lipoprotein; HDL-C=High-density lipoprotein cholesterol; CIMT=Carotid intima-media thickness; WC=Waist circumference; ALT=Alanine aminotransferase; GGT=Gamma-glutamyl transferase; ALP=Alkaline phosphatase